aβ42 peptides Search Results


90
Meso Scale Diagnostics LLC two-site monoclonal antibody (mab)-based sandwich elisa assays
Two Site Monoclonal Antibody (Mab) Based Sandwich Elisa Assays, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a%CE%B242+peptides/us09938263-758-23-46?v=Meso+Scale+Diagnostics+LLC
Average 90 stars, based on 1 article reviews
two-site monoclonal antibody (mab)-based sandwich elisa assays - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Bachem i31e/e22g β 42
Measuring the neurotoxicity of Aβ mutants by their effect on fly longevity. (A) The average neurotoxicity (Stox) of a single line of flies expressing <t>E22G</t> Aβ42 (○) compared with that of two independent lines of flies expressing I31E/E22G Aβ42 (□ and ♢), one line of WT Aβ40 (Δ), and one line of WT Aβ42 (+). (B) The average neurotoxicity of a single line of flies expressing WT Aβ40 (○) or WT Aβ42 (♢) compared with those of two independent lines of flies expressing E3R Aβ40 (□ and Δ); 100 flies divided equally into 10 tubes were analyzed for each line. Stox for each tube (n = 10 flies per tube) was calculated from the median survival determined by Kaplan-Meier survival analysis (see Materials and Methods). Differences between lines (n = 10 tubes) were analyzed for significance using the Mann Whitney U-test (∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001).
I31e/E22g β 42, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a%CE%B242+peptides/pmc02856165-66-12-29?v=Bachem
Average 90 stars, based on 1 article reviews
i31e/e22g β 42 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
JPT Peptide Technologies GmbH aβ42 variants (wild type, a2t and a2v mutants, purity >95% by hplc/c18)
Measuring the neurotoxicity of Aβ mutants by their effect on fly longevity. (A) The average neurotoxicity (Stox) of a single line of flies expressing <t>E22G</t> Aβ42 (○) compared with that of two independent lines of flies expressing I31E/E22G Aβ42 (□ and ♢), one line of WT Aβ40 (Δ), and one line of WT Aβ42 (+). (B) The average neurotoxicity of a single line of flies expressing WT Aβ40 (○) or WT Aβ42 (♢) compared with those of two independent lines of flies expressing E3R Aβ40 (□ and Δ); 100 flies divided equally into 10 tubes were analyzed for each line. Stox for each tube (n = 10 flies per tube) was calculated from the median survival determined by Kaplan-Meier survival analysis (see Materials and Methods). Differences between lines (n = 10 tubes) were analyzed for significance using the Mann Whitney U-test (∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001).
Aβ42 Variants (Wild Type, A2t And A2v Mutants, Purity >95% By Hplc/C18), supplied by JPT Peptide Technologies GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a%CE%B242+peptides/pmc04223304-81-2-20?v=JPT+Peptide+Technologies+GmbH
Average 90 stars, based on 1 article reviews
aβ42 variants (wild type, a2t and a2v mutants, purity >95% by hplc/c18) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
InContext Inc ad csf biomarkers
Measuring the neurotoxicity of Aβ mutants by their effect on fly longevity. (A) The average neurotoxicity (Stox) of a single line of flies expressing <t>E22G</t> Aβ42 (○) compared with that of two independent lines of flies expressing I31E/E22G Aβ42 (□ and ♢), one line of WT Aβ40 (Δ), and one line of WT Aβ42 (+). (B) The average neurotoxicity of a single line of flies expressing WT Aβ40 (○) or WT Aβ42 (♢) compared with those of two independent lines of flies expressing E3R Aβ40 (□ and Δ); 100 flies divided equally into 10 tubes were analyzed for each line. Stox for each tube (n = 10 flies per tube) was calculated from the median survival determined by Kaplan-Meier survival analysis (see Materials and Methods). Differences between lines (n = 10 tubes) were analyzed for significance using the Mann Whitney U-test (∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001).
Ad Csf Biomarkers, supplied by InContext Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a%CE%B242+peptides/pm40551285-29-14-23?v=InContext+Inc
Average 90 stars, based on 1 article reviews
ad csf biomarkers - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
BIOTAGE the fragment peptides of e22p-aβ42
Characterization of immunoreactivity of 11A1 antibody. ( A ) Assessment of the binding affinity of 11A1 antibody against various synthetic Aβ peptides. <t>E22P-Aβ42</t> (green), E22P-Aβ9-35ox (black), E22P-Aβ11-35ox (red), E22P-Aβ16-35ox (blue), and E22P-Aβ11-34 (orange) were synthesized and the binding affinity of 11A1 antibody for each peptide was assessed by Enzyme immunoassay. The 11A1 antibody exhibited high binding affinity for E22P-Aβ42 and E22P-Aβ9-35ox. Data are expressed as mean ± SD of three independent measurements. ( B ) Comparison of 11A1 antibody staining pattern with that of 6E10, 4G8, and OC antibodies. Postmortem human frontal cortex sections of an Alzheimer’s disease patient were stained with 6E10 (left panel), 4G8 (center left panel), OC (center right panel) and 11A1 (right panel) antibodies. Senile plaques (arrow heads) and vascular amyloid (arrows) are identified by 11A1 antibody with a similar pattern to that of the other three Aβ antibodies. The images were taken under 20x objective lens. Scale bar 50 µm. ( C and D) Assessment of 11A1 cross-reactivity against APP. Histological sections of human cingulate gyrus with traumatic axonal injury were stained with 22C11 (APP antibody) (left panel) and 11A1 (right panel) antibodies. The traumatic axonal balloons display intense signal with the antibody for APP (arrowheads), but these lesions are not stained with 11A1 antibody. ( C ) The images were taken under 20x objective lens. Scale bar 50 µm. ( D ) The images were taken under 40x objective lens. Scale bar 20 µm. ( E ) Testing 11A1 antibody specificity for Aβ toxic conformer in senile plaques and blood vessels. 11A1 antibody was pre-incubated without (left panel) or with (right panel) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissues with the primary antibody. The pre-incubation with immunogen abrogates the signal in senile plaques and blood vessels. The images were taken under 20x objective lens. Scale bar 50 µm.
The Fragment Peptides Of E22p Aβ42, supplied by BIOTAGE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a%CE%B242+peptides/pmc06237870-368-4-27?v=BIOTAGE
Average 90 stars, based on 1 article reviews
the fragment peptides of e22p-aβ42 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Creoptix Inc aβ42 peptide (20 ug/ml in na acetate ph 4.5)
Characterization of immunoreactivity of 11A1 antibody. ( A ) Assessment of the binding affinity of 11A1 antibody against various synthetic Aβ peptides. <t>E22P-Aβ42</t> (green), E22P-Aβ9-35ox (black), E22P-Aβ11-35ox (red), E22P-Aβ16-35ox (blue), and E22P-Aβ11-34 (orange) were synthesized and the binding affinity of 11A1 antibody for each peptide was assessed by Enzyme immunoassay. The 11A1 antibody exhibited high binding affinity for E22P-Aβ42 and E22P-Aβ9-35ox. Data are expressed as mean ± SD of three independent measurements. ( B ) Comparison of 11A1 antibody staining pattern with that of 6E10, 4G8, and OC antibodies. Postmortem human frontal cortex sections of an Alzheimer’s disease patient were stained with 6E10 (left panel), 4G8 (center left panel), OC (center right panel) and 11A1 (right panel) antibodies. Senile plaques (arrow heads) and vascular amyloid (arrows) are identified by 11A1 antibody with a similar pattern to that of the other three Aβ antibodies. The images were taken under 20x objective lens. Scale bar 50 µm. ( C and D) Assessment of 11A1 cross-reactivity against APP. Histological sections of human cingulate gyrus with traumatic axonal injury were stained with 22C11 (APP antibody) (left panel) and 11A1 (right panel) antibodies. The traumatic axonal balloons display intense signal with the antibody for APP (arrowheads), but these lesions are not stained with 11A1 antibody. ( C ) The images were taken under 20x objective lens. Scale bar 50 µm. ( D ) The images were taken under 40x objective lens. Scale bar 20 µm. ( E ) Testing 11A1 antibody specificity for Aβ toxic conformer in senile plaques and blood vessels. 11A1 antibody was pre-incubated without (left panel) or with (right panel) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissues with the primary antibody. The pre-incubation with immunogen abrogates the signal in senile plaques and blood vessels. The images were taken under 20x objective lens. Scale bar 50 µm.
Aβ42 Peptide (20 Ug/Ml In Na Acetate Ph 4.5), supplied by Creoptix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a%CE%B242+peptides/pm39382238-290-0-18?v=Creoptix+Inc
Average 90 stars, based on 1 article reviews
aβ42 peptide (20 ug/ml in na acetate ph 4.5) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Peptide Specialty Laboratories aβ42 g33a peptides
Characterization of immunoreactivity of 11A1 antibody. ( A ) Assessment of the binding affinity of 11A1 antibody against various synthetic Aβ peptides. <t>E22P-Aβ42</t> (green), E22P-Aβ9-35ox (black), E22P-Aβ11-35ox (red), E22P-Aβ16-35ox (blue), and E22P-Aβ11-34 (orange) were synthesized and the binding affinity of 11A1 antibody for each peptide was assessed by Enzyme immunoassay. The 11A1 antibody exhibited high binding affinity for E22P-Aβ42 and E22P-Aβ9-35ox. Data are expressed as mean ± SD of three independent measurements. ( B ) Comparison of 11A1 antibody staining pattern with that of 6E10, 4G8, and OC antibodies. Postmortem human frontal cortex sections of an Alzheimer’s disease patient were stained with 6E10 (left panel), 4G8 (center left panel), OC (center right panel) and 11A1 (right panel) antibodies. Senile plaques (arrow heads) and vascular amyloid (arrows) are identified by 11A1 antibody with a similar pattern to that of the other three Aβ antibodies. The images were taken under 20x objective lens. Scale bar 50 µm. ( C and D) Assessment of 11A1 cross-reactivity against APP. Histological sections of human cingulate gyrus with traumatic axonal injury were stained with 22C11 (APP antibody) (left panel) and 11A1 (right panel) antibodies. The traumatic axonal balloons display intense signal with the antibody for APP (arrowheads), but these lesions are not stained with 11A1 antibody. ( C ) The images were taken under 20x objective lens. Scale bar 50 µm. ( D ) The images were taken under 40x objective lens. Scale bar 20 µm. ( E ) Testing 11A1 antibody specificity for Aβ toxic conformer in senile plaques and blood vessels. 11A1 antibody was pre-incubated without (left panel) or with (right panel) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissues with the primary antibody. The pre-incubation with immunogen abrogates the signal in senile plaques and blood vessels. The images were taken under 20x objective lens. Scale bar 50 µm.
Aβ42 G33a Peptides, supplied by Peptide Specialty Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a%CE%B242+peptides/pmc03098494-243-16-19?v=Peptide+Specialty+Laboratories
Average 90 stars, based on 1 article reviews
aβ42 g33a peptides - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
ABclonal Biotechnology aβ42 peptides with a substitution of arg5 to gly (r5g)
Dimerization propensities of Aβ42 (green) and <t>Aβ40</t> (red).
Aβ42 Peptides With A Substitution Of Arg5 To Gly (R5g), supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a%CE%B242+peptides/pmc09673141-265-4-20?v=ABclonal+Biotechnology
Average 90 stars, based on 1 article reviews
aβ42 peptides with a substitution of arg5 to gly (r5g) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
ChinaPeptide Co Ltd synthetic human aβ (1-42) peptides aβ42
Dimerization propensities of Aβ42 (green) and <t>Aβ40</t> (red).
Synthetic Human Aβ (1 42) Peptides Aβ42, supplied by ChinaPeptide Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a%CE%B242+peptides/pmc08741852-44-0-9?v=ChinaPeptide+Co+Ltd
Average 90 stars, based on 1 article reviews
synthetic human aβ (1-42) peptides aβ42 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Braincare Inc fitc-aβ42 peptide
Dimerization propensities of Aβ42 (green) and <t>Aβ40</t> (red).
Fitc Aβ42 Peptide, supplied by Braincare Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a%CE%B242+peptides/pmc10916500__sj___pdf___1___aja___10__1177_15333175241236251-43-6-15?v=Braincare+Inc
Average 90 stars, based on 1 article reviews
fitc-aβ42 peptide - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
NeurOp Inc aβ42 peptide
Dimerization propensities of Aβ42 (green) and <t>Aβ40</t> (red).
Aβ42 Peptide, supplied by NeurOp Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a%CE%B242+peptides/pm38673907-76-12-0?v=NeurOp+Inc
Average 90 stars, based on 1 article reviews
aβ42 peptide - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Gendanio Inc aβ42 peptides
The aggregation of <t>Aβ42</t> into Aβ fibrils. ( a ) The fluorescence intensity of ThT was obtained by incubation of Aβ42 (Aβ; blue line), Aβ42 mixed with BSP (Aβ-BSP; red line) in PBS at 37 °C for 14 days. The green line represents the fluorescence intensity of ThT in PBS only (PBS). ( b ) The TEM image of Aβ42 monomers without aggregation on day 0; ( c ) the Aβ42 aggregated into thick and compact Aβ fibrils on day 7; ( d ) BSP reduced aggregation of Aβ42 with reduced thickness and loose packing of Aβ fibrils on day 7. The scale bar is 0.2 μm. ( n = 6, # p < 0.05 compared to control group, * p < 0.05 compared to Aβ group).
Aβ42 Peptides, supplied by Gendanio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a%CE%B242+peptides/pmc08657612-153-0-5?v=Gendanio+Inc
Average 90 stars, based on 1 article reviews
aβ42 peptides - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Measuring the neurotoxicity of Aβ mutants by their effect on fly longevity. (A) The average neurotoxicity (Stox) of a single line of flies expressing E22G Aβ42 (○) compared with that of two independent lines of flies expressing I31E/E22G Aβ42 (□ and ♢), one line of WT Aβ40 (Δ), and one line of WT Aβ42 (+). (B) The average neurotoxicity of a single line of flies expressing WT Aβ40 (○) or WT Aβ42 (♢) compared with those of two independent lines of flies expressing E3R Aβ40 (□ and Δ); 100 flies divided equally into 10 tubes were analyzed for each line. Stox for each tube (n = 10 flies per tube) was calculated from the median survival determined by Kaplan-Meier survival analysis (see Materials and Methods). Differences between lines (n = 10 tubes) were analyzed for significance using the Mann Whitney U-test (∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001).

Journal:

Article Title: Intrinsic Determinants of Neurotoxic Aggregate Formation by the Amyloid β Peptide

doi: 10.1016/j.bpj.2009.12.4320

Figure Lengend Snippet: Measuring the neurotoxicity of Aβ mutants by their effect on fly longevity. (A) The average neurotoxicity (Stox) of a single line of flies expressing E22G Aβ42 (○) compared with that of two independent lines of flies expressing I31E/E22G Aβ42 (□ and ♢), one line of WT Aβ40 (Δ), and one line of WT Aβ42 (+). (B) The average neurotoxicity of a single line of flies expressing WT Aβ40 (○) or WT Aβ42 (♢) compared with those of two independent lines of flies expressing E3R Aβ40 (□ and Δ); 100 flies divided equally into 10 tubes were analyzed for each line. Stox for each tube (n = 10 flies per tube) was calculated from the median survival determined by Kaplan-Meier survival analysis (see Materials and Methods). Differences between lines (n = 10 tubes) were analyzed for significance using the Mann Whitney U-test (∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001).

Article Snippet: The A β peptides A β 40 , A β 42 , E22G A β 42, I31E/E22G A β 42 , and E3R A β 40 were purchased from Bachem (Weil am Rhein, Germany) dissolved in trifluoroacetic acid, and sonicated for 30 s on ice.

Techniques: Expressing, MANN-WHITNEY

Predicted aggregation propensity scores

Journal:

Article Title: Intrinsic Determinants of Neurotoxic Aggregate Formation by the Amyloid β Peptide

doi: 10.1016/j.bpj.2009.12.4320

Figure Lengend Snippet: Predicted aggregation propensity scores

Article Snippet: The A β peptides A β 40 , A β 42 , E22G A β 42, I31E/E22G A β 42 , and E3R A β 40 were purchased from Bachem (Weil am Rhein, Germany) dissolved in trifluoroacetic acid, and sonicated for 30 s on ice.

Techniques:

Aggregation propensity profiles of Aβ40 (solid line) and E22G Aβ42 (dashed line), indicating the locations in negative peaks of the two mutants studied here (E3R Aβ40 and I31E/E22G Aβ40).

Journal:

Article Title: Intrinsic Determinants of Neurotoxic Aggregate Formation by the Amyloid β Peptide

doi: 10.1016/j.bpj.2009.12.4320

Figure Lengend Snippet: Aggregation propensity profiles of Aβ40 (solid line) and E22G Aβ42 (dashed line), indicating the locations in negative peaks of the two mutants studied here (E3R Aβ40 and I31E/E22G Aβ40).

Article Snippet: The A β peptides A β 40 , A β 42 , E22G A β 42, I31E/E22G A β 42 , and E3R A β 40 were purchased from Bachem (Weil am Rhein, Germany) dissolved in trifluoroacetic acid, and sonicated for 30 s on ice.

Techniques:

Measurement of the kinetics of aggregation and the types of aggregates formed by Aβ40, E22G Aβ42, and their mutants. (A) Progression of the aggregation reactions for E22G Aβ42 (solid circles) and E22G/I31E Aβ42 (open circles) monitored by ThT fluorescence spectroscopy. (B) The progression of the aggregation reactions for Aβ40 (solid squares) and E3R Aβ40 (open squares) was monitored by ThT fluorescence spectroscopy. (C and D) Transmission electron micrographs of samples from the end points of the E22G Aβ42 and I31E/E22G Aβ42 aggregation reactions shown in A indicate that fibrils were formed by both peptides. (E and F) Transmission electron micrographs of samples from the end points of the Aβ40 and E3R Aβ40 aggregation reactions shown in B indicate that fibrils were formed by both peptides. Scale bar = 200 μm.

Journal:

Article Title: Intrinsic Determinants of Neurotoxic Aggregate Formation by the Amyloid β Peptide

doi: 10.1016/j.bpj.2009.12.4320

Figure Lengend Snippet: Measurement of the kinetics of aggregation and the types of aggregates formed by Aβ40, E22G Aβ42, and their mutants. (A) Progression of the aggregation reactions for E22G Aβ42 (solid circles) and E22G/I31E Aβ42 (open circles) monitored by ThT fluorescence spectroscopy. (B) The progression of the aggregation reactions for Aβ40 (solid squares) and E3R Aβ40 (open squares) was monitored by ThT fluorescence spectroscopy. (C and D) Transmission electron micrographs of samples from the end points of the E22G Aβ42 and I31E/E22G Aβ42 aggregation reactions shown in A indicate that fibrils were formed by both peptides. (E and F) Transmission electron micrographs of samples from the end points of the Aβ40 and E3R Aβ40 aggregation reactions shown in B indicate that fibrils were formed by both peptides. Scale bar = 200 μm.

Article Snippet: The A β peptides A β 40 , A β 42 , E22G A β 42, I31E/E22G A β 42 , and E3R A β 40 were purchased from Bachem (Weil am Rhein, Germany) dissolved in trifluoroacetic acid, and sonicated for 30 s on ice.

Techniques: Fluorescence, Spectroscopy, Transmission Assay

Time-course analysis by TEM of the aggregation of E22G Aβ42 and I31E/E22G Aβ42. (A–C) TEM images taken throughout the aggregation reaction of E22G Aβ42 (t = 0 min, 15 min, and 6 days, respectively). (D–F) TEM images taken throughout the aggregation reaction of I31E/E22G Aβ42 (0 min, 15 min, and 6 days, respectively). Scale bar = 200 nm. (G) The size distributions of aggregates of E22G Aβ42 (solid line) and E22G/I31E Aβ42 (dashed line) determined by SEC performed immediately after dissolution of the peptides.

Journal:

Article Title: Intrinsic Determinants of Neurotoxic Aggregate Formation by the Amyloid β Peptide

doi: 10.1016/j.bpj.2009.12.4320

Figure Lengend Snippet: Time-course analysis by TEM of the aggregation of E22G Aβ42 and I31E/E22G Aβ42. (A–C) TEM images taken throughout the aggregation reaction of E22G Aβ42 (t = 0 min, 15 min, and 6 days, respectively). (D–F) TEM images taken throughout the aggregation reaction of I31E/E22G Aβ42 (0 min, 15 min, and 6 days, respectively). Scale bar = 200 nm. (G) The size distributions of aggregates of E22G Aβ42 (solid line) and E22G/I31E Aβ42 (dashed line) determined by SEC performed immediately after dissolution of the peptides.

Article Snippet: The A β peptides A β 40 , A β 42 , E22G A β 42, I31E/E22G A β 42 , and E3R A β 40 were purchased from Bachem (Weil am Rhein, Germany) dissolved in trifluoroacetic acid, and sonicated for 30 s on ice.

Techniques:

Characterization of immunoreactivity of 11A1 antibody. ( A ) Assessment of the binding affinity of 11A1 antibody against various synthetic Aβ peptides. E22P-Aβ42 (green), E22P-Aβ9-35ox (black), E22P-Aβ11-35ox (red), E22P-Aβ16-35ox (blue), and E22P-Aβ11-34 (orange) were synthesized and the binding affinity of 11A1 antibody for each peptide was assessed by Enzyme immunoassay. The 11A1 antibody exhibited high binding affinity for E22P-Aβ42 and E22P-Aβ9-35ox. Data are expressed as mean ± SD of three independent measurements. ( B ) Comparison of 11A1 antibody staining pattern with that of 6E10, 4G8, and OC antibodies. Postmortem human frontal cortex sections of an Alzheimer’s disease patient were stained with 6E10 (left panel), 4G8 (center left panel), OC (center right panel) and 11A1 (right panel) antibodies. Senile plaques (arrow heads) and vascular amyloid (arrows) are identified by 11A1 antibody with a similar pattern to that of the other three Aβ antibodies. The images were taken under 20x objective lens. Scale bar 50 µm. ( C and D) Assessment of 11A1 cross-reactivity against APP. Histological sections of human cingulate gyrus with traumatic axonal injury were stained with 22C11 (APP antibody) (left panel) and 11A1 (right panel) antibodies. The traumatic axonal balloons display intense signal with the antibody for APP (arrowheads), but these lesions are not stained with 11A1 antibody. ( C ) The images were taken under 20x objective lens. Scale bar 50 µm. ( D ) The images were taken under 40x objective lens. Scale bar 20 µm. ( E ) Testing 11A1 antibody specificity for Aβ toxic conformer in senile plaques and blood vessels. 11A1 antibody was pre-incubated without (left panel) or with (right panel) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissues with the primary antibody. The pre-incubation with immunogen abrogates the signal in senile plaques and blood vessels. The images were taken under 20x objective lens. Scale bar 50 µm.

Journal: Scientific Reports

Article Title: Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques

doi: 10.1038/s41598-018-35004-3

Figure Lengend Snippet: Characterization of immunoreactivity of 11A1 antibody. ( A ) Assessment of the binding affinity of 11A1 antibody against various synthetic Aβ peptides. E22P-Aβ42 (green), E22P-Aβ9-35ox (black), E22P-Aβ11-35ox (red), E22P-Aβ16-35ox (blue), and E22P-Aβ11-34 (orange) were synthesized and the binding affinity of 11A1 antibody for each peptide was assessed by Enzyme immunoassay. The 11A1 antibody exhibited high binding affinity for E22P-Aβ42 and E22P-Aβ9-35ox. Data are expressed as mean ± SD of three independent measurements. ( B ) Comparison of 11A1 antibody staining pattern with that of 6E10, 4G8, and OC antibodies. Postmortem human frontal cortex sections of an Alzheimer’s disease patient were stained with 6E10 (left panel), 4G8 (center left panel), OC (center right panel) and 11A1 (right panel) antibodies. Senile plaques (arrow heads) and vascular amyloid (arrows) are identified by 11A1 antibody with a similar pattern to that of the other three Aβ antibodies. The images were taken under 20x objective lens. Scale bar 50 µm. ( C and D) Assessment of 11A1 cross-reactivity against APP. Histological sections of human cingulate gyrus with traumatic axonal injury were stained with 22C11 (APP antibody) (left panel) and 11A1 (right panel) antibodies. The traumatic axonal balloons display intense signal with the antibody for APP (arrowheads), but these lesions are not stained with 11A1 antibody. ( C ) The images were taken under 20x objective lens. Scale bar 50 µm. ( D ) The images were taken under 40x objective lens. Scale bar 20 µm. ( E ) Testing 11A1 antibody specificity for Aβ toxic conformer in senile plaques and blood vessels. 11A1 antibody was pre-incubated without (left panel) or with (right panel) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissues with the primary antibody. The pre-incubation with immunogen abrogates the signal in senile plaques and blood vessels. The images were taken under 20x objective lens. Scale bar 50 µm.

Article Snippet: The fragment peptides of E22P-Aβ42 for ElA of 11A1 were synthesized in a stepwise fashion on 0.1 mmol of preloaded Fmoc-L-Met-PEG-PS or Fmoc-L-Leu-PEG-PS resin by a synthesizer, Biotage ® initiator + Alstra TM (Biotage Japan) using the Fmoc method.

Techniques: Binding Assay, Synthesized, Enzyme-linked Immunosorbent Assay, Staining, Incubation

11A1 immunoreactivity in pericapillary spaces. ( A and B ) Representative images were obtained under 63x objective lens. Pericapillary spaces in inferior parietal cortex, layer V, immunostained with 11A1 and Collagen IV. The rows of figures correspond to three age groups: early 30 s, middle 40 s, and early 60 s. Left panels show the 11A1 signal, middle panels indicate the Collagen IV signal and right panels show merged images. ( A ) Capillary cross sections, ( B ) capillary longitudinal sections. Scale bars ( A and B) , 5 µm. ( C ) Verification of 11A1 antibody’s specificity against Aβ toxic conformer in pericapillary space of the three age groups. The 11A1 antibody was pre-incubated with (bottom panels) or without (top panels) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissues with the primary antibody. The pre-incubation with immunogen abrogates the 11A1 signal around Collagen IV signal (magenta). Images were obtained under 20x objective lens. Scale bar 20 µm. ( D ) Percentage of pericapillary spaces labeled with 11A1 in measured area across age-spectrum (30-65 years). The relationship with age is not statistically significant before age 45 (p = 0.82), but it becomes highly significant after age 45 (p = 0.0006) by the Piecewise regression. ( E ) Number of cross sectional pericapillary spaces in measured area across age-spectrum (30–65 years). There is no significant change in the number of cross sectional capillary pericapillary spaces with age ( P = 0.496).

Journal: Scientific Reports

Article Title: Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques

doi: 10.1038/s41598-018-35004-3

Figure Lengend Snippet: 11A1 immunoreactivity in pericapillary spaces. ( A and B ) Representative images were obtained under 63x objective lens. Pericapillary spaces in inferior parietal cortex, layer V, immunostained with 11A1 and Collagen IV. The rows of figures correspond to three age groups: early 30 s, middle 40 s, and early 60 s. Left panels show the 11A1 signal, middle panels indicate the Collagen IV signal and right panels show merged images. ( A ) Capillary cross sections, ( B ) capillary longitudinal sections. Scale bars ( A and B) , 5 µm. ( C ) Verification of 11A1 antibody’s specificity against Aβ toxic conformer in pericapillary space of the three age groups. The 11A1 antibody was pre-incubated with (bottom panels) or without (top panels) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissues with the primary antibody. The pre-incubation with immunogen abrogates the 11A1 signal around Collagen IV signal (magenta). Images were obtained under 20x objective lens. Scale bar 20 µm. ( D ) Percentage of pericapillary spaces labeled with 11A1 in measured area across age-spectrum (30-65 years). The relationship with age is not statistically significant before age 45 (p = 0.82), but it becomes highly significant after age 45 (p = 0.0006) by the Piecewise regression. ( E ) Number of cross sectional pericapillary spaces in measured area across age-spectrum (30–65 years). There is no significant change in the number of cross sectional capillary pericapillary spaces with age ( P = 0.496).

Article Snippet: The fragment peptides of E22P-Aβ42 for ElA of 11A1 were synthesized in a stepwise fashion on 0.1 mmol of preloaded Fmoc-L-Met-PEG-PS or Fmoc-L-Leu-PEG-PS resin by a synthesizer, Biotage ® initiator + Alstra TM (Biotage Japan) using the Fmoc method.

Techniques: Incubation, Labeling

11A1 immunoreactivity in neurons. ( A and B ) Representative images were obtained under 63x objective lens. Cortical neurons of inferior parietal cortex, layer V, co-stained with 11A1 and MAP2 antibodies and 11A1, MAP2 and Cathepsin D antibodies. The rows of figures correspond to three age groups: early 30 s, middle 40 s, and early 60 s. ( A ) Left panels show the 11A1 signal (green), middle panels indicate MAP2 signal (red) and right panels show merged images. Scale bar 5 µm. ( B ) Left panels show the 11A1 signal, middle panels indicate Cathepsin D signal and right panels show merged images. The white contours in the merged images indicates the cell shape identified by MAP2. Intracellular 11A1 immunoreactivity (green) partially colocalized with Cathepsin D signal (Magenta). Scale bar 5 µm. ( C ) Verification of 11A1 antibody’s specificity against Aβ toxic conformer in neurons of the three age groups. 11A1 antibody was pre-incubated with (bottom panels) or without (top panels) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissue sections with the primary antibody. The pre-incubation with immunogen abrogates the 11A1 signal (green) in and around MAP2 signals (magenta). Images were obtained under 20x objective lens. Scale bar 20 µm. ( D ) Percentage of cortical neurons labeled with 11A1 in measured area across the age-spectrum (30–65 years). The relationship with age is not significant (p = 0.807). ( E ) Number of neurons in measured area across the age-spectrum (30–65 years). There is no significant change in the number of neurons with age (p = 0.6061).

Journal: Scientific Reports

Article Title: Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques

doi: 10.1038/s41598-018-35004-3

Figure Lengend Snippet: 11A1 immunoreactivity in neurons. ( A and B ) Representative images were obtained under 63x objective lens. Cortical neurons of inferior parietal cortex, layer V, co-stained with 11A1 and MAP2 antibodies and 11A1, MAP2 and Cathepsin D antibodies. The rows of figures correspond to three age groups: early 30 s, middle 40 s, and early 60 s. ( A ) Left panels show the 11A1 signal (green), middle panels indicate MAP2 signal (red) and right panels show merged images. Scale bar 5 µm. ( B ) Left panels show the 11A1 signal, middle panels indicate Cathepsin D signal and right panels show merged images. The white contours in the merged images indicates the cell shape identified by MAP2. Intracellular 11A1 immunoreactivity (green) partially colocalized with Cathepsin D signal (Magenta). Scale bar 5 µm. ( C ) Verification of 11A1 antibody’s specificity against Aβ toxic conformer in neurons of the three age groups. 11A1 antibody was pre-incubated with (bottom panels) or without (top panels) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissue sections with the primary antibody. The pre-incubation with immunogen abrogates the 11A1 signal (green) in and around MAP2 signals (magenta). Images were obtained under 20x objective lens. Scale bar 20 µm. ( D ) Percentage of cortical neurons labeled with 11A1 in measured area across the age-spectrum (30–65 years). The relationship with age is not significant (p = 0.807). ( E ) Number of neurons in measured area across the age-spectrum (30–65 years). There is no significant change in the number of neurons with age (p = 0.6061).

Article Snippet: The fragment peptides of E22P-Aβ42 for ElA of 11A1 were synthesized in a stepwise fashion on 0.1 mmol of preloaded Fmoc-L-Met-PEG-PS or Fmoc-L-Leu-PEG-PS resin by a synthesizer, Biotage ® initiator + Alstra TM (Biotage Japan) using the Fmoc method.

Techniques: Staining, Incubation, Labeling

11A1 immunoreactivity in protoplasmic astrocytes. ( A and B ) Representative images were obtained under 63x objective lens. Protoplasmic astrocytes of human inferior parietal cortex, layer V, immunostained with 11A1 and ALDH1L1 antibodies and 11A1, GFAP and Cathepsin D antibodies. The rows of figures correspond to three age groups: early 30 s, middle 40 s, and early 60 s. (A) Left panels show the 11A1 signal (green), middle panels correspond to the ALDH1L1 signal (red) and right panels show the merged images. Scale bar 5 µm. ( B ) Left panels show the 11A1 signal, middle panels correspond to the Cathepsin D signal (magenta) and right panels show the merged images. The white contours in the merged images indicate the cell shape identified by GFAP. Separate localization of the 11A1 immunoreactivity and Cathepsin D signals in the astrocytes is demonstrated. Scale bar 5 µm. ( C ) Verification of 11A1 antibody’s specificity against Aβ toxic conformer in protoplasmic astrocytes of the three age groups. The 11A1 antibody was pre-incubated with (bottom panels) or without (top panels) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissue sections with primary antibody. The pre-incubation with immunogen abrogates the 11A1 signal (green) in and around ALDH1L1 signal (magenta). Images were obtained under 20x objective lens. Scale bar 20 µm. ( D ) Percentage of protoplasmic astrocytes labeled with 11A1 of the astrocytes in measured area across the age-spectrum (30–65 years). The percentage of 11A1 labeled astrocytes gradually increases by age (p = 0.020). ( E ) Number of the astrocytes in measured area across the age-spectrum (30–65 years). Number of astrocytes gradually increases by age (p = 0.014).

Journal: Scientific Reports

Article Title: Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques

doi: 10.1038/s41598-018-35004-3

Figure Lengend Snippet: 11A1 immunoreactivity in protoplasmic astrocytes. ( A and B ) Representative images were obtained under 63x objective lens. Protoplasmic astrocytes of human inferior parietal cortex, layer V, immunostained with 11A1 and ALDH1L1 antibodies and 11A1, GFAP and Cathepsin D antibodies. The rows of figures correspond to three age groups: early 30 s, middle 40 s, and early 60 s. (A) Left panels show the 11A1 signal (green), middle panels correspond to the ALDH1L1 signal (red) and right panels show the merged images. Scale bar 5 µm. ( B ) Left panels show the 11A1 signal, middle panels correspond to the Cathepsin D signal (magenta) and right panels show the merged images. The white contours in the merged images indicate the cell shape identified by GFAP. Separate localization of the 11A1 immunoreactivity and Cathepsin D signals in the astrocytes is demonstrated. Scale bar 5 µm. ( C ) Verification of 11A1 antibody’s specificity against Aβ toxic conformer in protoplasmic astrocytes of the three age groups. The 11A1 antibody was pre-incubated with (bottom panels) or without (top panels) its immunogen, E22P-Aβ9-35ox peptide, prior to incubation of tissue sections with primary antibody. The pre-incubation with immunogen abrogates the 11A1 signal (green) in and around ALDH1L1 signal (magenta). Images were obtained under 20x objective lens. Scale bar 20 µm. ( D ) Percentage of protoplasmic astrocytes labeled with 11A1 of the astrocytes in measured area across the age-spectrum (30–65 years). The percentage of 11A1 labeled astrocytes gradually increases by age (p = 0.020). ( E ) Number of the astrocytes in measured area across the age-spectrum (30–65 years). Number of astrocytes gradually increases by age (p = 0.014).

Article Snippet: The fragment peptides of E22P-Aβ42 for ElA of 11A1 were synthesized in a stepwise fashion on 0.1 mmol of preloaded Fmoc-L-Met-PEG-PS or Fmoc-L-Leu-PEG-PS resin by a synthesizer, Biotage ® initiator + Alstra TM (Biotage Japan) using the Fmoc method.

Techniques: Incubation, Labeling

Dimerization propensities of Aβ42 (green) and Aβ40 (red).

Journal: ACS Chemical Neuroscience

Article Title: Key Residue for Aggregation of Amyloid-β Peptides

doi: 10.1021/acschemneuro.2c00358

Figure Lengend Snippet: Dimerization propensities of Aβ42 (green) and Aβ40 (red).

Article Snippet: The synthetic Aβ42 and Aβ40 peptides with a substitution of Arg5 to Gly (R5G) or Glu (R5E) were purchased from Abclonal.

Techniques:

Intermolecular contact probabilities of C α atoms for (a) Aβ42 and (b) Aβ40. Probabilities with which the residues in (c) Aβ42 and (d) Aβ40 form β-strands with the corresponding length.

Journal: ACS Chemical Neuroscience

Article Title: Key Residue for Aggregation of Amyloid-β Peptides

doi: 10.1021/acschemneuro.2c00358

Figure Lengend Snippet: Intermolecular contact probabilities of C α atoms for (a) Aβ42 and (b) Aβ40. Probabilities with which the residues in (c) Aβ42 and (d) Aβ40 form β-strands with the corresponding length.

Article Snippet: The synthetic Aβ42 and Aβ40 peptides with a substitution of Arg5 to Gly (R5G) or Glu (R5E) were purchased from Abclonal.

Techniques:

Intramolecular contact probabilities of C α atoms for (a) Aβ42 and (b) Aβ40. Probability distributions with respect to the number of intramolecular and intermolecular β-bridges for (c) Aβ42 and (d) Aβ40.

Journal: ACS Chemical Neuroscience

Article Title: Key Residue for Aggregation of Amyloid-β Peptides

doi: 10.1021/acschemneuro.2c00358

Figure Lengend Snippet: Intramolecular contact probabilities of C α atoms for (a) Aβ42 and (b) Aβ40. Probability distributions with respect to the number of intramolecular and intermolecular β-bridges for (c) Aβ42 and (d) Aβ40.

Article Snippet: The synthetic Aβ42 and Aβ40 peptides with a substitution of Arg5 to Gly (R5G) or Glu (R5E) were purchased from Abclonal.

Techniques:

Free-energy landscapes for (a) Aβ42 and (b) Aβ40 with respect to the corresponding first and second principal components (PC1 and PC2). The local-minimum free-energy states are labeled as (a) states A–E for Aβ42 and (b) states A′–E′ for Aβ40. The units of the free-energy landscapes are kcal/mol. Representative dimer structures in (a) states A–E and (b) states A′–E′ are also shown.

Journal: ACS Chemical Neuroscience

Article Title: Key Residue for Aggregation of Amyloid-β Peptides

doi: 10.1021/acschemneuro.2c00358

Figure Lengend Snippet: Free-energy landscapes for (a) Aβ42 and (b) Aβ40 with respect to the corresponding first and second principal components (PC1 and PC2). The local-minimum free-energy states are labeled as (a) states A–E for Aβ42 and (b) states A′–E′ for Aβ40. The units of the free-energy landscapes are kcal/mol. Representative dimer structures in (a) states A–E and (b) states A′–E′ are also shown.

Article Snippet: The synthetic Aβ42 and Aβ40 peptides with a substitution of Arg5 to Gly (R5G) or Glu (R5E) were purchased from Abclonal.

Techniques: Labeling

Intramolecular contact probabilities between residues for (a) Aβ42 and (b) Aβ40. Here, all atoms, including the side-chain atoms, except the hydrogen atoms, are considered in calculating the contact probabilities. (c) Schematic illustration where the β-hairpin of Aβ42 is stabilized by the contacts between the C-terminus and Arg5 and between E22 and K28.

Journal: ACS Chemical Neuroscience

Article Title: Key Residue for Aggregation of Amyloid-β Peptides

doi: 10.1021/acschemneuro.2c00358

Figure Lengend Snippet: Intramolecular contact probabilities between residues for (a) Aβ42 and (b) Aβ40. Here, all atoms, including the side-chain atoms, except the hydrogen atoms, are considered in calculating the contact probabilities. (c) Schematic illustration where the β-hairpin of Aβ42 is stabilized by the contacts between the C-terminus and Arg5 and between E22 and K28.

Article Snippet: The synthetic Aβ42 and Aβ40 peptides with a substitution of Arg5 to Gly (R5G) or Glu (R5E) were purchased from Abclonal.

Techniques:

Intermolecular contact probabilities between residues for (a) Aβ42 and (b) Aβ40. Here, all atoms, including the side-chain atoms, except the hydrogen atoms, are considered in calculating the contact probabilities.

Journal: ACS Chemical Neuroscience

Article Title: Key Residue for Aggregation of Amyloid-β Peptides

doi: 10.1021/acschemneuro.2c00358

Figure Lengend Snippet: Intermolecular contact probabilities between residues for (a) Aβ42 and (b) Aβ40. Here, all atoms, including the side-chain atoms, except the hydrogen atoms, are considered in calculating the contact probabilities.

Article Snippet: The synthetic Aβ42 and Aβ40 peptides with a substitution of Arg5 to Gly (R5G) or Glu (R5E) were purchased from Abclonal.

Techniques:

The aggregation of Aβ42 into Aβ fibrils. ( a ) The fluorescence intensity of ThT was obtained by incubation of Aβ42 (Aβ; blue line), Aβ42 mixed with BSP (Aβ-BSP; red line) in PBS at 37 °C for 14 days. The green line represents the fluorescence intensity of ThT in PBS only (PBS). ( b ) The TEM image of Aβ42 monomers without aggregation on day 0; ( c ) the Aβ42 aggregated into thick and compact Aβ fibrils on day 7; ( d ) BSP reduced aggregation of Aβ42 with reduced thickness and loose packing of Aβ fibrils on day 7. The scale bar is 0.2 μm. ( n = 6, # p < 0.05 compared to control group, * p < 0.05 compared to Aβ group).

Journal: International Journal of Molecular Sciences

Article Title: Modified Low-Temperature Extraction Method for Isolation of Bletilla striata Polysaccharide as Antioxidant for the Prevention of Alzheimer’s Disease

doi: 10.3390/ijms222312760

Figure Lengend Snippet: The aggregation of Aβ42 into Aβ fibrils. ( a ) The fluorescence intensity of ThT was obtained by incubation of Aβ42 (Aβ; blue line), Aβ42 mixed with BSP (Aβ-BSP; red line) in PBS at 37 °C for 14 days. The green line represents the fluorescence intensity of ThT in PBS only (PBS). ( b ) The TEM image of Aβ42 monomers without aggregation on day 0; ( c ) the Aβ42 aggregated into thick and compact Aβ fibrils on day 7; ( d ) BSP reduced aggregation of Aβ42 with reduced thickness and loose packing of Aβ fibrils on day 7. The scale bar is 0.2 μm. ( n = 6, # p < 0.05 compared to control group, * p < 0.05 compared to Aβ group).

Article Snippet: Aβ42 peptides were synthesized by Gendanio Biotech Inc. (New Taipei City, Taiwan).

Techniques: Fluorescence, Incubation, Control

The LIVE/DEAD staining of N2a cells in ( a ) the control: cells cultured in medium only, ( b ) positive control: cells treated with zinc diethyldithiocarbamate, ( c ) negative control: cells treated with aluminum oxide, ( d ) BSP: cells treated with an extracted solution of BSP, and ( e ) Aβ-BSP: cells treated with Aβ42 and BSP. ( f ) Quantitative results of survival rate in N2a cells. *** p < 0.001 compared with control.

Journal: International Journal of Molecular Sciences

Article Title: Modified Low-Temperature Extraction Method for Isolation of Bletilla striata Polysaccharide as Antioxidant for the Prevention of Alzheimer’s Disease

doi: 10.3390/ijms222312760

Figure Lengend Snippet: The LIVE/DEAD staining of N2a cells in ( a ) the control: cells cultured in medium only, ( b ) positive control: cells treated with zinc diethyldithiocarbamate, ( c ) negative control: cells treated with aluminum oxide, ( d ) BSP: cells treated with an extracted solution of BSP, and ( e ) Aβ-BSP: cells treated with Aβ42 and BSP. ( f ) Quantitative results of survival rate in N2a cells. *** p < 0.001 compared with control.

Article Snippet: Aβ42 peptides were synthesized by Gendanio Biotech Inc. (New Taipei City, Taiwan).

Techniques: Staining, Control, Cell Culture, Positive Control, Negative Control

Antioxidant activity of extracted BSP. DCFDA was used to measure the intracellular ROS in N2a cells without any treatment (control), treated with Aβ42 (Aβ), and Aβ42 and BSP (Aβ42-BSP). ( n = 6, # p < 0.05 compared to control group, * p < 0.05 compared to Aβ group).

Journal: International Journal of Molecular Sciences

Article Title: Modified Low-Temperature Extraction Method for Isolation of Bletilla striata Polysaccharide as Antioxidant for the Prevention of Alzheimer’s Disease

doi: 10.3390/ijms222312760

Figure Lengend Snippet: Antioxidant activity of extracted BSP. DCFDA was used to measure the intracellular ROS in N2a cells without any treatment (control), treated with Aβ42 (Aβ), and Aβ42 and BSP (Aβ42-BSP). ( n = 6, # p < 0.05 compared to control group, * p < 0.05 compared to Aβ group).

Article Snippet: Aβ42 peptides were synthesized by Gendanio Biotech Inc. (New Taipei City, Taiwan).

Techniques: Antioxidant Activity Assay, Control